Halozyme therapeutics, inc. (HALO)
Income statement / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09
Revenues:
Total revenues

195,992

151,862

316,613

146,691

135,057

75,334

54,799

42,325

56,086

13,624

13,671

Operating expenses:
Cost of product sales

45,546

10,136

31,152

33,206

29,245

22,732

6,246

1,094

257

985

311

Research and development

140,804

150,252

150,643

150,842

93,236

79,696

96,640

70,044

57,563

51,773

56,614

Selling, general and administrative

77,252

60,804

53,816

45,853

40,028

35,942

32,347

24,812

18,104

15,122

15,203

Total operating expenses

263,602

221,192

235,611

229,901

162,509

138,370

135,233

95,950

75,925

67,881

72,129

Operating (loss) income

-67,610

-69,330

81,002

-83,210

-27,452

-63,036

-80,434

-53,625

-19,838

-54,257

-58,458

Other income (expense):
Interest income, net

-

-

-

-

-

-

-

-

-

49

100

Other Income, net

-

-

-

-

-

-

-

-

-

966

-3

Investment and other income, net

6,986

7,578

2,592

1,326

422

242

229

73

69

1,015

97

Interest expense

11,627

18,041

21,984

19,977

5,201

5,581

3,274

0

0

-

-

Net (loss) income before income taxes

-72,251

-79,793

61,610

-101,861

-32,231

-68,375

-

-

-

-

-

Income tax expense

-11

537

-1,361

1,162

0

0

-

-

-

-

-

Net Income (Loss) Attributable to Parent

-72,240

-80,330

62,971

-103,023

-32,231

-68,375

-83,479

-53,552

-19,769

-53,241

-58,360

Net (loss) income per share:
Basic and diluted (usd per share)

-0.50

-0.56

-

-

-

-0.56

-0.74

-0.48

-0.19

-0.56

-0.67

Net income (loss) per share, Basic

-

-

0.46

-0.81

-0.25

-

-

-

-

-

-

Net income (loss) per share, Diluted

-0.50

-0.56

0.45

-0.81

-0.25

-

-

-

-

-

-

Shares used in computing net (loss) income per share:
Basic and diluted (in shares)

144,329

143,599

-

-

-

122,690

112,805

111,077

102,566

94,357

86,700

Shares used in computing basic net income (loss) per share

144,329

143,599

136,419

127,964

126,704

-

-

-

-

-

-

Shares used in computing diluted net income (loss) per share

144,329

143,599

139,068

127,964

126,704

-

-

-

-

-

-

Comprehensive Loss

-

-

-

-

-

-

-

-

-

-53,241

-

Royalties
Total revenues

69,899

78,981

63,507

50,984

30,975

9,425

33

0

-

-

-

Product sales, net
Total revenues

66,048

28,234

50,396

53,392

46,082

37,823

24,439

2,887

1,836

895

970

Collaborative Agreements [Member]
Total revenues

60,045

44,647

202,710

42,315

58,000

28,086

30,327

39,438

54,250

12,728

12,700